{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T05:22:29Z","timestamp":1793510549720,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00415-025-13439-9","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:46:58Z","timestamp":1762624018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Big multiple sclerosis data network: novel modelling approaches for real-world data analysis"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6329-8946","authenticated-orcid":false,"given":"M.","family":"Trojano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2308-1731","authenticated-orcid":false,"given":"P.","family":"Iaffaldano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Copetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Drahota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3536-1813","authenticated-orcid":false,"given":"L.","family":"Forsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. F.","family":"Mouresan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1506-3827","authenticated-orcid":false,"given":"L.","family":"Pontieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Spelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Toschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Butzkueven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hillert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1915-0036","authenticated-orcid":false,"given":"D.","family":"Horakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0972-5222","authenticated-orcid":false,"given":"M.","family":"Magyari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Vukusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lucisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kalincik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,8]]},"reference":[{"issue":"14","key":"13439_CR1","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jama.2019.4064","volume":"321","author":"E Basch","year":"2019","unstructured":"Basch E, Schrag D (2019) The evolving uses of \u201creal-world\u201d data. JAMA 321(14):1359\u20131360. https:\/\/doi.org\/10.1001\/jama.2019.4064","journal-title":"JAMA"},{"key":"13439_CR2","unstructured":"U.S. food and drug administration. Framework for FDA\u2019s real-world evidence program. (2018); https:\/\/www.fda.gov\/media\/120060\/download?attachment; European medicines agency, Accessed 14 Jan, 2025"},{"key":"13439_CR3","unstructured":"Real-world evidence framework to support EU regulatory decision-making: Report on the experience gained with regulator-led studies from september 2021 to february 2023. (2023); https:\/\/www.ema.europa.eu\/en\/documents\/report\/real-world-evidence-framework-support-eu-regulatory-decision-making-report-experience-gained-regulator-led-studies-september-2021-february-2023_en.pdf, Accessed 14 Jan, 2025"},{"issue":"6","key":"13439_CR4","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1007\/s00415-024-12303-6","volume":"271","author":"A Glaser","year":"2024","unstructured":"Glaser A, Butzkueven H, van der Walt A et al (2024) Big multiple sclerosis data network: an international registry research network. J Neurol 271(6):3616\u20133624. https:\/\/doi.org\/10.1007\/s00415-024-12303-6","journal-title":"J Neurol"},{"issue":"2","key":"13439_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nrneurol.2016.188","volume":"13","author":"M Trojano","year":"2017","unstructured":"Trojano M, Tintore M, Montalban X et al (2017) Treatment decisions in multiple sclerosis - insights from real-world observational studies. Nat Rev Neurol 13(2):105\u2013118. https:\/\/doi.org\/10.1038\/nrneurol.2016.188","journal-title":"Nat Rev Neurol"},{"key":"13439_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519849513","author":"F Pellegrini","year":"2019","unstructured":"Pellegrini F et al (2019) A proof-of-concept application of a novel scoring approach for personalised medicine in multiple sclerosis. Mult Scler J. https:\/\/doi.org\/10.1177\/1352458519849513","journal-title":"Mult Scler J"},{"key":"13439_CR7","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S0140-6736(18)30475-6","volume":"391","author":"L Kappos","year":"2018","unstructured":"Kappos L, Bar-Or A, Cree BAC et al (2018) Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study. Lancet 391:1263\u20131273","journal-title":"Lancet"},{"key":"13439_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15706","author":"I Diouf","year":"2023","unstructured":"Diouf I, Malpas CB, Sharmin S et al (2023) Variability of the response to immunotherapy among sub-groups of patients with multiple sclerosis. Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.15706","journal-title":"Eur J Neurol"},{"key":"13439_CR9","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1093\/brain\/awx185","volume":"140","author":"T Kalincik","year":"2017","unstructured":"Kalincik T, Manouchehrinia A, Sobisek L et al (2017) Towards personalised therapy for multiple sclerosis: prediction of individual treatment response. Brain 140:2426\u20132443","journal-title":"Brain"},{"key":"13439_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/biostatistics\/kxu037","volume":"16","author":"B Claggett","year":"2015","unstructured":"Claggett B, Tian L, Castagno D, Wei LJ (2015) Treatment selections using risk-benefit profiles based on data from comparative randomised clinical trials with multiple endpoints. Biostatistics 16:60\u201372","journal-title":"Biostatistics"},{"key":"13439_CR11","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1212\/WNL.0000000000010991","volume":"96","author":"F Bovis","year":"2021","unstructured":"Bovis F, Kalincik T, Lublin F et al (2021) Treatment response score to glatiramer acetate or interferon beta-1a. Neurology 96:e214\u2013e227","journal-title":"Neurology"},{"key":"13439_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2015.04.005","author":"EW Steyerberg","year":"2015","unstructured":"Steyerberg EW, Harrell FE (2015) Prediction models need appropriate internal, internaleexternal, and external validation. J Clin Epidemiol. https:\/\/doi.org\/10.1016\/j.jclinepi.2015.04.005","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"13439_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","volume":"21","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg EW et al (2010) Assessing the performance of prediction models: a framework for some traditional and novel measures. Epidemiology 21(1):128\u2013138","journal-title":"Epidemiology"},{"issue":"3","key":"13439_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/0272989X221143058","volume":"43","author":"K Chalkou","year":"2023","unstructured":"Chalkou K et al (2023) Decision curve analysis for personalised treatment choise between multiple options. Med Decis Making 43(3):337\u2013349","journal-title":"Med Decis Making"},{"key":"13439_CR15","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C (2016) Xgboost: a scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining. pp 785\u2013794","DOI":"10.1145\/2939672.2939785"},{"issue":"1","key":"13439_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L (2001) Random forests. Mach Learn 45(1):5\u201332","journal-title":"Mach Learn"},{"issue":"1","key":"13439_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12874-018-0482-1","volume":"18","author":"JL Katzman","year":"2018","unstructured":"Katzman JL et al (2018) DeepSurv: personalised treatment recommender system using a cox proportional hazards deep neural network. BMC Med Res Methodol 18(1):24","journal-title":"BMC Med Res Methodol"},{"key":"13439_CR18","first-page":"02158","volume":"1608","author":"R Ranganath","year":"2016","unstructured":"Ranganath R et al (2016) Deep survival analysis. arXiv 1608:02158","journal-title":"arXiv"},{"key":"13439_CR19","first-page":"4765","volume":"30","author":"SM Lundberg","year":"2017","unstructured":"Lundberg SM, Lee SI (2017) A unified approach to interpreting model predictions. Adv Neural Inf Process Syst 30:4765\u20134774","journal-title":"Adv Neural Inf Process Syst"},{"issue":"2","key":"13439_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/brainsci13020198","volume":"13","author":"A Conti","year":"2023","unstructured":"Conti A et al (2023) An interpretable machine learning model to predict cortical atrophy in multiple sclerosis. Brain Sci 13(2):198","journal-title":"Brain Sci"},{"issue":"3","key":"13439_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab134","volume":"3","author":"CA Treaba","year":"2021","unstructured":"Treaba CA et al (2021) Cortical and phase rim lesions on 7 T MRI as markers of multiple sclerosis disease progression. Brain Commun 3(3):fcab134","journal-title":"Brain Commun"},{"issue":"1","key":"13439_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1023\/A:1007379606734","volume":"28","author":"R Caruana","year":"1997","unstructured":"Caruana R (1997) Multitask learning. Mach Learn 28(1):41\u201375","journal-title":"Mach Learn"},{"key":"13439_CR23","doi-asserted-by":"publisher","DOI":"10.1109\/TKDE.2021.3070203","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Yang Q (2021) A survey on multi-task learning. IEEE Trans Knowl Data Eng. https:\/\/doi.org\/10.1109\/TKDE.2021.3070203","journal-title":"IEEE Trans Knowl Data Eng"},{"key":"13439_CR24","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2409.20412","author":"J Verhaeghe","year":"2024","unstructured":"Verhaeghe J et al (2024) Conformal prediction for dose-response models with continuous treatments. arXiv 240920412. https:\/\/doi.org\/10.48550\/arXiv.2409.20412","journal-title":"arXiv 2409.20412"},{"issue":"27","key":"13439_CR25","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1073\/pnas.1510489113","volume":"113","author":"S Athey","year":"2016","unstructured":"Athey S, Imbens GW (2016) Recursive partitioning for heterogeneous causal effects. Proc Natl Acad Sci 113(27):7353\u20137360","journal-title":"Proc Natl Acad Sci"},{"issue":"523","key":"13439_CR26","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/01621459.2017.1319839","volume":"113","author":"S Wager","year":"2018","unstructured":"Wager S, Athey S (2018) Estimation and inference of heterogeneous treatment effects using random forests. J Am Stat Assoc 113(523):1228\u20131242","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"13439_CR27","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1111\/ectj.12097","volume":"21","author":"V Chernozhukov","year":"2018","unstructured":"Chernozhukov V et al (2018) Double\/debiased machine learning for treatment and structural parameters. Economet J 21(1):C1\u2013C68","journal-title":"Economet J"},{"issue":"9","key":"13439_CR28","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1177\/13524585221085733","volume":"28","author":"G Simoneau","year":"2022","unstructured":"Simoneau G, Pellegrini F, Debray T et al (2022) Recommendations for the use of propensity score methods in multiple sclerosis research. Mult Scler J 28(9):1467\u20131480","journal-title":"Mult Scler J"},{"issue":"1","key":"13439_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-022-01623-8","volume":"22","author":"M Lefort","year":"2022","unstructured":"Lefort M, Sharmin S, Andersen JB et al (2022) Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis. BMC Med Res Methodol 22(1):155. https:\/\/doi.org\/10.1186\/s12874-022-01623-8","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"13439_CR30","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/13524585231151394","volume":"29","author":"I Roos","year":"2023","unstructured":"Roos I, Diouf I, Sharmin S et al (2023) Comparative effectiveness in multiple sclerosis: a methodological comparison. Mult Scler J 29(3):326\u2013332","journal-title":"Mult Scler J"},{"issue":"10","key":"13439_CR31","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1177\/13524585211010128","volume":"27","author":"P Iaffaldano","year":"2021","unstructured":"Iaffaldano P, Lucisano G, Butzkueven H et al (2021) Early treatment delays long-term disability accrual in RRMS: results from the BMSD network. Mult Scler J 27(10):1543\u20131555","journal-title":"Mult Scler J"},{"issue":"10","key":"13439_CR32","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jamaneurol.2021.2738","volume":"78","author":"T Spelman","year":"2021","unstructured":"Spelman T, Magyari M, Piehl F et al (2021) Treatment escalation vs immediate initiation of highly effective treatment for patients with relapsing-remitting multiple sclerosis: data from two national strategies. JAMA Neurol 78(10):1197\u20131204","journal-title":"JAMA Neurol"},{"key":"13439_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.647811","volume":"12","author":"J Hillert","year":"2021","unstructured":"Hillert J, Magyari M, Soelberg S\u00f8rensen P et al (2021) Treatment switching and discontinuation over 20 years in the Big Multiple Sclerosis Data Network. Front Neurol 12:647811","journal-title":"Front Neurol"},{"key":"13439_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104803","volume":"76","author":"T Hrnciarova","year":"2023","unstructured":"Hrnciarova T, Drahota J, Spelman T et al (2023) Does initial high efficacy therapy surpass escalation treatment strategy? Mult Scler Relat Disord 76:104803","journal-title":"Mult Scler Relat Disord"},{"key":"13439_CR35","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2023.2293379","author":"T Spelman","year":"2023","unstructured":"Spelman T, Herring WL, Acosta C et al (2023) Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom. J Med Econ. https:\/\/doi.org\/10.1080\/13696998.2023.2293379","journal-title":"J Med Econ"},{"issue":"3","key":"13439_CR36","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/sim.9965","volume":"43","author":"J Mu\u00f1oz","year":"2024","unstructured":"Mu\u00f1oz J, Efthimiou O, Audigier V et al (2024) Multiple imputation of incomplete multilevel data using Heckman selection models. Stat Med 43(3):514\u2013533","journal-title":"Stat Med"},{"issue":"2","key":"13439_CR37","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001141","volume":"9","author":"P Iaffaldano","year":"2022","unstructured":"Iaffaldano P, Lucisano G, Manni A et al (2022) Risk of getting COVID-19 in people with multiple sclerosis: a case-control study. Neurol Neuroimmunol Neuroinflamm 9(2):e1141","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"13439_CR38","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001105","volume":"9","author":"MP Sormani","year":"2021","unstructured":"Sormani MP, Schiavetti I, Carmisciano L, MuSC-19 Study Group et al (2021) COVID-19 severity in multiple sclerosis: putting data into context. Neurol Neuroimmunol Neuroinflamm 9(1):e1105. https:\/\/doi.org\/10.1212\/NXI.0000000000001105","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"13439_CR39","doi-asserted-by":"publisher","DOI":"10.12688\/openreseurope.15701.2","volume":"3","author":"J Zeitlin","year":"2023","unstructured":"Zeitlin J, Philibert M, Estupi\u00f1\u00e1n-Romero F et al (2023) Developing and testing a protocol using a common data model for federated collection and analysis of national perinatal health indicators in Europe. Open Res Europe 3:54. https:\/\/doi.org\/10.12688\/openreseurope.15701.2","journal-title":"Open Res Europe"},{"issue":"2","key":"13439_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/jamiaopen\/ooae033","volume":"7","author":"A Sikora","year":"2024","unstructured":"Sikora A, Keats K, Murphy DJ et al (2024) A common data model for the standardization of intensive care unit medication features. JAMIA Open 7(2):ooae033. https:\/\/doi.org\/10.1093\/jamiaopen\/ooae033","journal-title":"JAMIA Open"},{"key":"13439_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2016.18","volume":"3","author":"MD Wilkinson","year":"2016","unstructured":"Wilkinson MD, Dumontier M, Aalbersberg IJJ et al (2016) The FAIR guiding principles for scientific data management and stewardship. Sci Data 3:160018. https:\/\/doi.org\/10.1038\/sdata.2016.18","journal-title":"Sci Data"},{"issue":"1","key":"13439_CR42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/amiajnl-2011-000376","volume":"19","author":"JM Overhage","year":"2012","unstructured":"Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE (2012) Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc 19(1):54\u201360. https:\/\/doi.org\/10.1136\/amiajnl-2011-000376","journal-title":"J Am Med Inform Assoc"},{"issue":"9","key":"13439_CR43","doi-asserted-by":"publisher","first-page":"600","DOI":"10.7326\/0003-4819-153-9-201011020-00010","volume":"153","author":"PE Stang","year":"2010","unstructured":"Stang PE, Ryan PB, Racoosin JA et al (2010) Advancing the science for active surveillance: rationale and design for the observational medical outcomes partnership. Ann Intern Med 153(9):600\u2013606. https:\/\/doi.org\/10.7326\/0003-4819-153-9-201011020-00010","journal-title":"Ann Intern Med"},{"key":"13439_CR44","unstructured":"Drahota J et al. Common data model in multiple sclerosis collaborative research: proved concept and lessons learned in the big MSData network. [Manuscript in preparation]"},{"issue":"2","key":"13439_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","volume":"20","author":"EG Brown","year":"1999","unstructured":"Brown EG, Wood L, Wood S (1999) The medical dictionary for regulatory activities (MedDRA). Drug Saf 20(2):109\u2013117. https:\/\/doi.org\/10.2165\/00002018-199920020-00002","journal-title":"Drug Saf"},{"issue":"1","key":"13439_CR46","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev-biodatasci-122220-115746","volume":"7","author":"R Li","year":"2024","unstructured":"Li R, Romano JD, Chen Y, Moore JH (2024) Centralized and federated models for the analysis of clinical data. Annu Rev Biomed Data Sci 7(1):179\u2013199. https:\/\/doi.org\/10.1146\/annurev-biodatasci-122220-115746","journal-title":"Annu Rev Biomed Data Sci"},{"key":"13439_CR47","first-page":"1273","volume-title":"Proceedings of the 20th international conference on artificial intelligence and statistics","author":"B McMahan","year":"2017","unstructured":"McMahan B, Moore E, Ramage D, Hampson S, Arcas BA (2017) Communication-efficient learning of deep networks from decentralized data. In: Singh A, Zhu J (eds) Proceedings of the 20th international conference on artificial intelligence and statistics. PMLR, Cambridge, pp 1273\u20131282"},{"issue":"2","key":"13439_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101419","volume":"5","author":"ZL Teo","year":"2024","unstructured":"Teo ZL, Jin L, Li S et al (2024) Federated machine learning in healthcare: a systematic review on clinical applications and technical architecture. Cell Rep Med 5(2):101419. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101419","journal-title":"Cell Rep Med"},{"issue":"5","key":"13439_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pdig.0000033","volume":"1","author":"MG Crowson","year":"2022","unstructured":"Crowson MG, Moukheiber D, Ar\u00e9valo AR et al (2022) A systematic review of federated learning applications for biomedical data. PLoS Digit Health 1(5):e0000033. https:\/\/doi.org\/10.1371\/journal.pdig.0000033","journal-title":"PLoS Digit Health"},{"issue":"5","key":"13439_CR50","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/ije\/dyq111","volume":"39","author":"M Wolfson","year":"2010","unstructured":"Wolfson M, Wallace SE, Masca N et al (2010) DataSHIELD: resolving a conflict in contemporary bioscience\u2013performing a pooled analysis of individual-level data without sharing the data. Int J Epidemiol 39(5):1372\u20131382. https:\/\/doi.org\/10.1093\/ije\/dyq111","journal-title":"Int J Epidemiol"},{"key":"13439_CR51","doi-asserted-by":"publisher","unstructured":"Forsberg L, Hillert J, Mouresan EF, Glaser A, Magyari M, Pontieri L (2023) Assessing likelihood of secondary progressive multiple sclerosis in Sweden and Denmark: a federated learning analysis unveiling modestly higher odds in Sweden. In: MSMilan2023 \u2013 Paper Poster \u2013 Session 2. Mult Scler. 29(3_suppl):394\u2013649. https:\/\/doi.org\/10.1177\/13524585231196194","DOI":"10.1177\/13524585231196194"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13439-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13439-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13439-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T15:30:31Z","timestamp":1765812631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13439-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,8]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["13439"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13439-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,8]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest with respect to the contents of the current study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"754"}}